BioCorRx Inc. (BICX)
Chart Events
Performance Outlook
| Previous Close | 4.4600 |
| Open | 4.4800 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 4.1000 - 4.4800 |
| 52 Week Range | 1.0100 - 8.1000 |
| Volume | |
| Avg. Volume | 2,593 |
| Market Cap | 27.432M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7950 |
| Earnings Date | Mar 28, 2022 - Apr 01, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
BioCorRx to Present at the H.C. Wainwright BioConnect 2022 Conference
ANAHEIM, CA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, CEO, CFO and Director of BioCorRx Inc., and Brady Granier, President and Director of BioCorRx Inc. and CEO of BioCorRx Pharmaceuticals Inc., will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022.
- GlobeNewswire
BioCorRx Appoints Drug Delivery Expert Jie Shen, Ph.D., to Scientific Advisory Board
ANAHEIM, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced the appointment of Dr. Jie Shen to the Scientific Advisory Board (SAB). Dr. Jie Shen is an Assistant Professor in the Departments of Biomedical and Pharmaceutical Sciences and Chemical Engineering at the University of Rhode Island (URI). Prior to joining URI, Dr. Shen wa
- GlobeNewswire
BioCorRx to Participate in the Benzinga All Access Event on December 2nd
ANAHEIM, CA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that Lourdes Felix, CEO, CFO and Director of BioCorRx, Inc. and Brady Granier, President and Director, CEO of BioCorRx Pharmaceuticals, will be participating in the Benzinga All Access event taking place on December 2, 2021. Ms. Felix and Mr. Granier are scheduled to pre
